US EditionBiotech Firm Cresilon Expands to 55K SF at Brooklyn’s Industry City
Summary by Commercial Observer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Biotech Firm Cresilon Expands to 55K SF at Brooklyn’s Industry City
Biotechnology company Cresilon has more than doubled its U.S. headquarters and lab space at Brooklyn’s Industry City. Cresilon, which develops and manufactures hemostatic medical devices, signed a 10-year expansion to tack on 28,000 square feet in the Sunset Park complex owned by Jamestown, Belvedere Capital, Cammeby’s International, FBE Limited and TPG Angelo Gordon, according to a press release. It’s a big upgrade in space for the Cresilon, wh…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
